INS and Hypoglycemia: Although exogenous insulin is essential for the treatment of type 1 diabetes (T1D), the association of insulin treatment with suboptimal glycemic control and an increased risk of weight gain and hypoglycemia (Paik and Blair, 2019) underscores the need for adjunctive treatments.